| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.6 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in IBM Rational Team Concert. This vulnerability affects unknown code of the component Project Handler. Such manipulation leads to cross site scripting. This vulnerability is referenced as CVE-2016-6037. It is possible to launch the attack remotely. No exploit is available.
Details
A vulnerability was found in IBM Rational Team Concert (affected version unknown). It has been rated as problematic. Affected by this issue is an unknown functionality of the component Project Handler. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. CVE summarizes:
IBM Rational Team Concert (RTC) is vulnerable to HTML injection. A remote attacker with project administrator privileges could send a project that contains malicious HTML code, which when the project is viewed, would be executed in the victim's Web browser within the security context of the hosting site. IBM X-Force ID: 116918.
The bug was discovered 05/04/2017. The weakness was published 05/10/2017 (Website). The advisory is shared for download at ibm.com. This vulnerability is handled as CVE-2016-6037 since 06/29/2016. The attack may be launched remotely. The successful exploitation needs a simple authentication. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
The vulnerability was handled as a non-public zero-day exploit for at least 6 days. During that time the estimated underground price was around $0-$5k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Similar entries are available at VDB-101059 and VDB-101062. Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 3.6VulDB Meta Temp Score: 3.6
VulDB Base Score: 2.4
VulDB Temp Score: 2.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 4.8
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
06/29/2016 🔍05/04/2017 🔍
05/10/2017 🔍
05/10/2017 🔍
05/11/2017 🔍
09/25/2020 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2016-6037 (🔍)
GCVE (CVE): GCVE-0-2016-6037
GCVE (VulDB): GCVE-100-101060
OSVDB: - CVE-2016-6037 - Ibm - Rational Quality Manager - Low
See also: 🔍
Entry
Created: 05/11/2017 12:46Updated: 09/25/2020 11:00
Changes: 05/11/2017 12:46 (57), 09/25/2020 11:00 (3)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.